Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 3/20 | 0.59 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.47 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 13/20 | 0.45 |
| ▸ | HTR1D | P28221 | 13/20 | 0.45 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | WDR5 | P61964 | 1/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGAV | P06756 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7478765 | 0.98 | CXCR4 (0.58) | CXCR4APOBEC3AAPOBEC3GHTR1AHTR1D | |
| SCHEMBL8585904 | 0.95 | CXCR4 (0.62) | CXCR4APOBEC3AAPOBEC3GHTR1AHTR1D | |
| SCHEMBL6440029 | 0.93 | CXCR4 (0.66) | CXCR4APOBEC3AAPOBEC3GHTR1AHTR1D | |
| SCHEMBL17887695 | 0.90 | CXCR4 (0.61) | CXCR4APOBEC3AAPOBEC3GHTR1AHTR1D | |
| SCHEMBL6301909 | 0.89 | CXCR4 (0.75) | CXCR4APOBEC3AAPOBEC3GHTR1AHTR1D | |
| Hydrochloric Acid SCHEMBL7541441 | 0.87 | CXCR4 (0.72) | CXCR4APOBEC3AAPOBEC3GHTR1AHTR1D | |
| SCHEMBL2493767 | 0.82 | CXCR4 (0.59) | CXCR4APOBEC3AAPOBEC3GHTR1AHTR1D | |
| SCHEMBL12343968 | 0.81 | CXCR4 (0.62) | CXCR4APOBEC3AAPOBEC3GHTR1AHTR1D | |
| SCHEMBL20016343 | 0.79 | CXCR4 (0.51) | CXCR4APOBEC3AAPOBEC3GHTR1AHTR1D | |
| SCHEMBL12341235 | 0.78 | CXCR4 (0.54) | CXCR4APOBEC3AAPOBEC3GHTR1AHTR1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0719138-B1 | IONTOPHORETIC DELIVERY OF AN ANTIMIGRAINE DRUG | JANSSEN PHARMACEUTICA NV (BE) | 1999-02-10 | — | — | EP | claimed |
| EP-0639192-B1 | (BENZODIOXAN, BENZOFURAN OR BENZOPYRAN)-ALKYLAMINO] ALKYL SUBSTITUTED GUANIDINES AS SELECTIVE VASCOCONSTRICTORS | JANSSEN PHARMACEUTICA NV (BE) | 1996-05-15 | — | — | EP | claimed |
| US-6005094-A | MIXTURE OF AN ACID RESISTANT, ANTISENSE OLIGONUCLEOTIDE AND A CARRIER; FOR ORAL ADMINISTRATION | GENTA INCORPORATED (US) | 1999-12-21 | — | — | US | disclosed |
| EP-0824342-B1 | PREPARATION OF FORMULATIONS FOR ELECTROTRANSPORT DRUG DELIVERY | ALZA CORP (US) | 1999-11-24 | — | — | EP | disclosed |
| US-5801179-A | TREATMENT OF MIGRAINES, HYPOTENSION, VENOUS INSUFFICIENCY | JANSSEN PHARMACEUTICA, NV (BE) | 1998-09-01 | — | — | US | disclosed |
| EP-0690716-A4 | OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACID pH | UNIV JOHNS HOPKINS (US) | 1997-05-02 | — | — | EP | disclosed |
| EP-0690716-A1 | OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACID pH | THE JOHNS HOPKINS UNIVERSITY (US) | 1996-01-10 | — | — | EP | disclosed |
| WO-1994015619-A1 | OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACID pH | THE JOHNS HOPKINS UNIVERSITY (US) | 1994-07-21 | — | — | WO | disclosed |